International AIDS Society
The 2nd International HIV/Viral Hepatitis Co-Infection Meeting

Affiliated Event (Pre-registration required)

Type: Meeting / Pre-conference
Organizer: CIHR Canadian HIV Trials Network (CTN)
Target audience: Conference delegates
Location: Sheraton Vancouver Wall Centre 1088 Burrard St, Vancouver
Vancouver, Canada
Schedule: 08:00 - 18:00, 17.07.2015
09:00 - 18:00, 18.07.2015


Viral hepatitis is now the most clinically important co-morbidity among people living with HIV. New, highly effective therapies that directly target hepatitis B (HBV) and C (HCV) will alter the landscape for co-infected patients. However, several barriers to access new therapies exist including low levels of screening, limited liver disease staging, and lack of hepatitis-specific education and training of HIV health care professionals. Specific themes of the meeting include: HCV therapeutic development and access; HBV prevention and management; optimizing HCV treatment costs and outcomes; complex issues in viral hepatitis management; and challenges and opportunities for scaling up viral hepatitis programs.

 

The organizers reserve the right to amend the programme.